GoingToMeet

The total R&D investment of bringing a new product to market has been estimated to be close to £400 million. Delays are expensive and even a few days could potentially cost millions of pounds. Each country has its own guidelines which can be highly regulated, so it is crucial to understand the complexities of conducting clinical trials in various parts of the EU.

SMi’s 6th annual conference on Conducting Clinical Trials in Europe is a must attend event that will cover regulatory developments in the European environment whilst paying close attention to the recent inclusion of paediatric studies for all clinical trials. It will also cover various aspects of patient recruitment and retention and will analyse key logistical challenges. Recognised experts from within the EU community will give best practice advice on which components are needed for a successful trial, including key requirements for good clinical practice, outsourcing and adequate inspections to ensure your company maximises its patient involvement and clinical trial supply.